NASDAQ:ALRN

Aileron Therapeutics

Stock

USD

Last Close

1.93

10/01 21:00

Market Cap

66.06M

Beta: 2.01

Volume Today

63.39K

Avg: 53.55K

PE Ratio

−1.68

PFCF: −1.64

Overview Financials API

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24
revenue
cost of revenue
gross profit
selling and marketing expenses										-13.85M -
general and administrative expenses	5.06M -		8.77M -	13.45M 53.43%	12.29M 8.63%	9.33M 24.10%	9.60M 2.86%	9.68M 0.86%	11.36M 17.32%	13.86M 22.07%
selling general and administrative expenses	5.06M -	7.89M 56.02%	8.77M 11.10%	13.45M 53.43%	12.29M 8.63%	9.33M 24.10%	9.60M 2.86%	9.68M 0.86%	11.36M 17.32%	13.86K 99.88%
research and development expenses	7.83M -	10.28M 31.21%	14.24M 38.57%	18.45M 29.56%	17.66M 4.26%	11.17M 36.78%	17.01M 52.32%	17.97M 5.64%	3.99M 77.79%	14.25K 99.64%
other expenses		-18.17M -					441K -	318K 27.89%	928K 191.82%
cost and expenses	12.89M -	18.17M 40.94%	23.01M 26.63%	31.90M 38.66%	29.96M 6.10%	20.50M 31.58%	26.61M 29.81%	27.65M 3.92%	16.28M 41.13%	65.11K 99.60%
operating expenses	12.89M -	18.17M 40.94%	23.01M 26.63%	31.90M 38.66%	29.96M 6.10%	20.50M 31.58%	26.61M 29.81%	27.65M 3.92%	16.28M 41.13%	65.11K 99.60%
interest expense								-318K -
ebitda	-12.57M -	-17.94M 42.74%	-22.88M 27.55%	-31.68M 38.49%	-29.80M 5.94%	-19.67M 33.99%	-26.88M 36.66%	-27.48M 2.21%	-16.28M 40.77%	-28.05M 72.33%
operating income	-12.89M -	-18.17M 40.94%	-23.01M 26.63%	-31.90M 38.66%	-29.96M 6.10%	-20.50M 31.58%	-26.61M 29.81%	-27.65M 3.92%	-16.28M 41.13%	-65.11M 300.05%
depreciation and amortization	325K -	232K 28.62%	129K 44.40%	218K 68.99%	155K 28.90%	824K 431.61%	-279K 133.86%	169K 160.57%		63K -
total other income expenses net	13K -	46K 253.85%	404K 778.26%	355K 12.13%	587K 65.35%	-661K 212.61%	400K 160.51%	318K 20.50%	544K 71.07%	800K 47.06%
income before tax	-12.88M -	-18.12M 40.73%	-22.60M 24.73%	-31.55M 39.56%	-29.37M 6.90%	-21.16M 27.96%	-26.20M 23.86%	-27.33M 4.29%	-15.73M 42.43%	-64.31M 308.80%
income tax expense				355K -	-587K 265.35%	661K 212.61%	-441K 166.72%	-318K 27.89%		-1.54M -
net income	-12.88M -	-18.12M 40.73%	-22.60M 24.73%	-31.55M 39.56%	-28.78M 8.76%	-21.82M 24.20%	-25.76M 18.09%	-27.01M 4.84%	-15.73M 41.76%	-62.88M 299.71%
weighted average shs out	545.72K -	545.72K 0%	372.15K 31.81%	736.91K 98.01%	1.23M 66.48%	1.74M 42.11%	4.44M 154.70%	4.54M 2.23%	4.60B 101,208.50%	17.94K 100.00%
weighted average shs out dil	545.72K -	545.72K 0%	372.15K 31.81%	736.91K 98.01%	1.23M 66.48%	1.74M 42.11%	4.44M 154.70%	4.54M 2.23%	4.60B 101,208.50%	17.94K 100.00%
eps	-23.60 -	-33.21 40.72%	-60.74 82.90%	-42.81 29.52%	-23.46 45.20%	-12.52 46.63%	-5.80 53.67%	-5.95 2.59%	-0.00 99.94%	-3.51 103,135.29%
epsdiluted	-23.60 -	-33.21 40.72%	-60.74 82.90%	-42.81 29.52%	-23.46 45.20%	-12.52 46.63%	-5.80 53.67%	-5.95 2.59%	-0.00 99.94%	-3.51 103,135.29%

All numbers in USD (except ratios and percentages)